FDA Inspection 884359 — Agnesian Healthcare IRB

Agnesian Healthcare IRB — FEI 3009793893

The FDA completed an inspection of Agnesian Healthcare IRB on Jun 17, 2014 in Fond Du Lac, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 17, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fond Du Lac, WI (United States)

Additional Details

IRB

Citations

IDCFRDescription
731621 CFR 56.115(a)(4)Copies of IRB/CI correspondence
731821 CFR 56.115(a)(2)Minutes of IRB meetings
732021 CFR 56.109(e)IRB approvals/disapprovals - general

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.